Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Alzheimer's Disease Trials
Contact E-mail clinical_trials@rush.edu

Click on the links below to learn about trials in Alzheimer’s disease and related dementias.

Included in this section:

Alzheimer's BACE1 Inhibitor Study: The purpose of this 20-month trial is to evaluate the safety and effectiveness of multiple doses of an experimental drug compared to placebo when given to people with Alzheimers disease.

Alzheimer's Genetics Family Study: The goal of this study is to find genetic factors that determine whether a person is at greater risk of getting Alzheimer's disease after the age of 60.

Anti-Amyloid Treatment in Asymptomatic Alzheimers : The purpose of this 3-year study is to test the hypothesis that solanezumab will slow the decline of perceived cognitive functions and performance of everyday activities, as compared with placebo, in persons with preclinical Alzheimers disease.

Biomarker Qualification for Risk of Mild Alzheimers Disease and Evaluation of Pioglitazone: The purpose of this 5-year study is to qualify the biomarker risk algorithm for prognosis of the risk of developing MCI due to AD, and evaluate the efficacy of pioglitazone to delay the onset of MCI due to AD in cognitively normal persons.

Efficacy and Safety Trial of MK-8931 for Prodromal Alzheimers: The purpose of this 4-year study is to evaluate the efficacy and safety of multiple doses of an experimental drug compared to placebo, as measured by overall clinical decline and/or progression, in subjects with prodromal AD.

Imaging Study to Detect Amyloid in the Brain: The purpose of this study is to test the ability of an experimental PET imaging compound to detect brain amyloid, a protein associated with Alzheimers disease.

Imaging Study to Detect to Amyloid in the Brain of People with Memory Problems: Imaging Study to Detect to Amyloid in the Brain of People with Memory Problems

Individuals Aged 70 or Over and Low-Dose Aspirin Use Study: The purpose of this study is to determine whether aspirin can prolong disability-free life by preventing thinking problems (such as memory loss and dementia), heart disease, stroke, certain cancers, and physical disability (such as walking difficulties) in healthy people over the age of 70.

Lu AE58054 in Alzheimers Patients Treated with Donepezil: The purpose of this 7-month study is to establish the efficacy and effect of multiple doses of an experimental drug compared to placebo as adjunctive therapy to donepezil in patients with Alzheimers disease.

Mild to Moderate Alzheimer's Disease Treatment Study: The purpose of this 20-month trial is to evaluate the safety and effectiveness of multiple doses of an experimental drug compared to placebo when given to people with Alzheimers disease.

The Effect of Passive Immunization on Mild Alzheimers Disease: The purpose of this 18-month study is to test whether solanezumab will slow the cognitive and functional decline of Alzheimers disease in patients with mild Alzheimers disease.



Promotional Information

Clinical Trials Home
Alzheimer's Disease Trials
Alzheimer's BACE1 Inhibitor Study
Alzheimer's Genetics Family Study
Anti-Amyloid Treatment in Asymptomatic Alzheimers
Biomarker Qualification for Risk of Mild Alzheimers Disease and Evaluation of Pioglitazone
Efficacy and Safety Trial of MK-8931 for Prodromal Alzheimers
Imaging Study to Detect Amyloid in the Brain
Imaging Study to Detect to Amyloid in the Brain of People with Memory Problems
Individuals Aged 70 or Over and Low-Dose Aspirin Use Study
Lu AE58054 in Alzheimers Patients Treated with Donepezil
Mild to Moderate Alzheimer's Disease Treatment Study
The Effect of Passive Immunization on Mild Alzheimers Disease

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois